| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Family Medicine, Medical University of South Carolina, Charleston, SC
2 Department of Family and Community Medicine, Christiana Care Health System, Wilmington, Del
CORRESPONDING AUTHOR: Arch G. Mainous III, PhD, Department of Family Medicine, Medical University of South Carolina, 295 Calhoun St, Charleston, SC 29425, mainouag{at}musc.edu
PURPOSE Transferrin saturation of more than 60% has been identified as a cancer risk factor. It is unclear whether dietary iron intake increases the risk of cancer among individuals with transferrin saturation of less than 60%. The purpose of this study was to examine the association of dietary iron intake and the risk of cancer among adults with increased transferrin saturation.
METHODS Analysis of a cohort study, the National Health and Nutrition Examination Survey I Epidemiologic Follow-Up Study, was performed. US adults (aged 25 to 74 years at baseline) were followed up from baseline in 1971–1974 to 1992 (N = 6,309).
RESULTS A total of 7.3% of the US population had a serum transferrin saturation of more than 45% at baseline. Intake of dietary iron was essentially uncorrelated with transferrin saturation (r = 0.04). Compared with individuals who had normal serum transferrin saturation and low dietary iron intake, individuals whose serum transferrin saturation was more than 45% and who had high dietary iron intake also had an increased adjusted relative risk of cancer (2.24; 95% confidence interval [CI], 1.02-4.89). Increased risk was not found for individuals with a transferrin saturation of more than 45% but a normal dietary iron intake (hazard ratio, 1.02; 95% CI, 0.69–1.49). Transferrin saturation levels could be set as low as 41%, and the individuals with high transferrin saturation and high dietary iron intake would still have an increased adjusted relative risk of cancer (hazard ratio, 2.00; 95% CI, 1.04–3.82).
CONCLUSIONS Among persons with increased transferrin saturation, a daily intake of dietary iron more than 18 mg is associated with an increased risk of cancer. Future research might focus on the benefits of dietary changes in those individuals with increased serum transferrin saturation.
Key Words: Cohort studies • transferrin saturation, diagnostic use • iron, dietary • cocarcinogenesis • diet
This article has been cited by other articles:
|
|
 |
|
  S. Kovac, K. Smith, G. J. Anderson, J. R. Burgess, A. Shulkes, and G. S. Baldwin Interrelationships between circulating gastrin and iron status in mice and humans Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G855 - G861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Hong, C. B. Ambrosone, J. Ahn, J.-Y. Choi, M. L. McCullough, V. L. Stevens, C. Rodriguez, M. J. Thun, and E. E. Calle Genetic Variability in Iron-Related Oxidative Stress Pathways (Nrf2, NQ01, NOS3, and HO-1), Iron Intake, and Risk of Postmenopausal Breast Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1784 - 1794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M J Brookes, S Hughes, F E Turner, G Reynolds, N Sharma, T Ismail, G Berx, A T McKie, N Hotchin, G J Anderson, et al. Modulation of iron transport proteins in human colorectal carcinogenesis Gut, October 1, 2006; 55(10): 1449 - 1460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Stange 'Another Compelling Idealized Model That Is Drastically Altered by the Ugly Facts on the Ground' Ann. Fam. Med, March 1, 2006; 4(2): 177 - 178. [Full Text] [PDF]
|
|
|
|
|
|
K. C. Stange In This Issue Ann. Fam. Med, March 1, 2005; 3(2): 98 - 99. [Full Text] [PDF]
|
|
Read all TRACK Comments
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
